FDC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE258B01022
  • NSEID: FDC
  • BSEID: 531599
INR
380.50
11.8 (3.2%)
BSENSE

Feb 09

BSE+NSE Vol: 55.51 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Senores Pharma.
Supriya Lifesci.
Innova Captab
Blue Jet Health
Shilpa Medicare
Aarti Pharma
Zota Health Care
Akums Drugs
FDC
SPARC
Sudeep Pharma

Why is FDC Ltd ?

1
Poor long term growth as Operating profit has grown by an annual rate -4.35% of over the last 5 years
2
Negative results in Dec 25
  • PBT LESS OI(Q) At Rs 36.37 cr has Fallen at -31.2% (vs previous 4Q average)
  • PAT(Q) At Rs 44.47 cr has Fallen at -21.1% (vs previous 4Q average)
  • ROCE(HY) Lowest at 12.51%
3
With ROE of 9.3, it has a Expensive valuation with a 2.5 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -20.21%, its profits have fallen by -15.1%
4
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -0.66% over the previous quarter and collectively hold 8.59% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
5
Below par performance in long term as well as near term
  • Along with generating -20.21% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is FDC for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
FDC
-19.88%
-0.74
27.21%
Sensex
7.94%
0.69
11.53%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
8.96%
EBIT Growth (5y)
-4.35%
EBIT to Interest (avg)
60.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.17
Sales to Capital Employed (avg)
0.85
Tax Ratio
24.64%
Dividend Payout Ratio
30.51%
Pledged Shares
0
Institutional Holding
8.59%
ROCE (avg)
17.80%
ROE (avg)
11.97%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
26
Industry P/E
32
Price to Book Value
2.47
EV to EBIT
25.43
EV to EBITDA
19.95
EV to Capital Employed
2.76
EV to Sales
2.69
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
10.64%
ROE (Latest)
9.27%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-16What is not working for the Company
PBT LESS OI(Q)

At Rs 36.37 cr has Fallen at -31.2% (vs previous 4Q average

PAT(Q)

At Rs 44.47 cr has Fallen at -21.1% (vs previous 4Q average

ROCE(HY)

Lowest at 12.51%

NET SALES(Q)

At Rs 464.71 cr has Fallen at -10.5% (vs previous 4Q average

NON-OPERATING INCOME(Q)

is 36.38 % of Profit Before Tax (PBT

EPS(Q)

Lowest at Rs 1.74

Loading Valuation Snapshot...

Here's what is not working for FDC

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 36.37 cr has Fallen at -31.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 52.83 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 44.47 cr has Fallen at -21.1% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 56.36 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 464.71 cr has Fallen at -10.5% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 519.36 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Non Operating Income - Quarterly
is 36.38 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Earnings per Share (EPS) - Quarterly
Lowest at Rs 1.74
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)